NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
UGRO Capital Q3 FY26: PAT Rises 23% YoY to ₹46.3 Cr; AUM Grows 40% to ₹15,454 Cr
UGRO Capital reported a robust performance for Q3 FY26, with Assets Under Management (AUM) growing 40% YoY to reach ₹15,454 Cr. Net Profit (PAT) increased by 23% YoY to ₹46.3 Cr, driven by a 19% growth in Net Total Income. The company demonstrated improved operational efficiency with collection efficiency rising to 99% and the cost of borrowing declining to 10.24%. While GNPA saw a marginal uptick to 2.2%, the overall asset quality remains stable with NNPA at 1.4%.
முக்கிய அம்சங்கள்
AUM increased by 40% YoY to ₹15,454 Cr, with Q3 disbursements at ₹2,217 Cr.Net Profit (PAT) grew 23% YoY to ₹46.3 Cr; Net Total Income rose 19% to ₹259.7 Cr.Cost of borrowing improved to 10.24% from 10.68% in the previous year's quarter.Asset quality remains healthy with GNPA at 2.2% and NNPA at 1.4%.Collection efficiency reached 99% in Q3 FY26, up from 96% in Q3 FY25.
👀 கவனிக்க வேண்டியவை
Investors should take confidence in the strong AUM growth and improving borrowing costs, which signal efficient scaling of the MSME lending model. The stock remains a growth play in the NBFC space, though asset quality trends in the 'Business Loan' segment (5.3% GNPA) warrant close monitoring.
Ugro Capital Q3 FY26 PAT Drops 83% YoY to ₹6.38 Cr; Nominee Director Resigns
Ugro Capital reported a sharp decline in standalone net profit for Q3 FY26, falling to ₹6.38 crore from ₹37.51 crore in the same quarter last year. While total income grew 16.5% YoY to ₹448.34 crore, the bottom line was severely impacted by a 41% surge in finance costs and a 45% increase in impairment provisions. Additionally, the company announced the resignation of Nominee Director Chetan Gupta and the proposed appointment of Ramanathan Subramanian Arun Kumar as a new Nominee Director for ClearSky Investment Holdings.
முக்கிய அம்சங்கள்
Standalone Net Profit plummeted 83% YoY to ₹6.38 crore in Q3 FY26 from ₹37.51 crore in Q3 FY25.Total Income increased by 16.5% YoY to ₹448.34 crore, though it declined slightly on a QoQ basis from ₹461.18 crore.Finance costs rose significantly to ₹236.55 crore, up 41% from ₹167.31 crore in the year-ago period.Impairment on financial instruments (provisions) increased to ₹59.97 crore compared to ₹41.28 crore in Q3 FY25.Chetan Gupta resigned as Non-Executive Nominee Director; Ramanathan Subramanian Arun Kumar to be appointed as Nominee Director for ClearSky Investment Holdings.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the sharp drop in profitability and rising impairment costs suggest pressure on margins and asset quality. Monitor management's commentary regarding the spike in finance costs and the outlook for credit losses in the coming quarters.
UGRO Capital is shifting its business model to focus on high-yield Emerging Market secured lending and Embedded merchant financing, while exiting low-yield, DSA-led channels. The company has identified ₹220 crore in annualized operating cost savings through structural rationalization and overhead optimization. This realignment aims to increase recurring interest income and improve earnings quality, targeting a sustainable ROA of 3-3.5%. Management expects no further equity dilution for the next three years, as growth will be funded primarily through internal accruals.
முக்கிய அம்சங்கள்
Identified ₹220 crore in annualized operating cost savings through exit of DSA-led verticals and overhead optimization.AUM grew to ₹15,454 crore as of Dec-25, with a target to have 73-85% of AUM in high-yield segments by FY28-29.Strategic exit from low-yield Prime LAP and Machinery loans to focus on segments with an average yield of 19%.No equity capital requirement for the next 3 years; future growth to be funded via internal accruals.Emerging Market branch network expanded to 300+ locations with a focus on improving branch productivity to ₹0.80-0.85 Cr per month.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive move toward better margins and capital efficiency, though they should monitor the execution of cost-cutting measures. The commitment to avoid equity dilution for three years provides a strong floor for valuation.
Ugro Capital Assigned 'CareEdge B+/Stable' Rating for USD 50 Million ECB
CareEdge Global has assigned a 'CareEdge B+/Stable' rating to Ugro Capital's USD 50 million External Commercial Borrowing. The company's AUM stood at ₹12,226 crore as of September 2025, which increased to approximately ₹15,500 crore following the acquisition of Profectus Capital in December 2025. While the portfolio is 70% secured, profitability remains modest with an ROA of 1.9% for FY25, impacted by high operating costs of 3.6%. Investors should note the elevated leverage of 5.5x (including off-book) and a Capital Adequacy Ratio that recently dipped to 19.4%, close to covenant thresholds.
முக்கிய அம்சங்கள்
Assigned 'CareEdge B+/Stable' rating for a USD 50 million External Commercial Borrowing (ECB).Combined AUM reached ~₹15,500 crore post-acquisition of Profectus Capital's ₹3,400 crore book.Asset quality metrics reported with GNPA at 3.0% and NNPA at 1.7% as of September 30, 2025.Operating costs are high at 3.6% of managed assets, with management targeting improvements by FY27.Capital Adequacy Ratio (CAR) stood at 19.4% in March 2025, leaving a thin buffer against 20% debt covenants.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's progress in reducing operating expenses and improving ROA post-merger. The thin capital buffer suggests a potential need for further equity infusion to support aggressive growth targets.
Ugro Capital Rating Reaffirmed at 'A'; Profectus Acquisition to Boost AUM to ₹15,400 Cr
Acuité Ratings has reaffirmed and withdrawn the 'ACUITE A' rating for ₹156.28 Cr of NCDs following redemption and issuer request. More importantly, the rating has been removed from 'Rating Watch' as Ugro Capital successfully completed the acquisition of Profectus Capital, which brings an AUM of ~₹3,400 Cr. The combined entity is expected to reach an AUM of ₹15,400 Cr, representing a 29% growth with a more robust 75% secured asset mix. While asset quality has improved with GNPA at 2.35%, the company's return on average assets (RoAA) remains moderate at 1.86%.
முக்கிய அம்சங்கள்
Acquisition of Profectus Capital completed, projected to increase total AUM by 29% to ₹15,400 Cr.On-book GNPA improved to 2.35% as of March 31, 2025, compared to 3.09% in the previous year.Combined entity asset mix to shift towards 75% secured and 25% unsecured loans for better diversification.Planned equity raise of ₹1,315 Cr for FY2026 via rights issue and Compulsorily Convertible Debentures (CCDs).FY2025 PAT reported at ₹143.93 Cr with a moderate RoAA of 1.86% and gearing at 3.37 times.
👀 கவனிக்க வேண்டியவை
The completion of the Profectus acquisition is a major milestone that improves the company's scale and asset quality profile. Investors should monitor the integration process and look for improvements in the RoAA as the combined entity scales.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
UGRO Capital Allots 3.89 Lakh Equity Shares Following CCD Conversion at Rs 185/Share
UGRO Capital has approved the allotment of 3,89,183 equity shares of face value Rs. 10 each to CCD holders who exercised their conversion rights. This conversion is part of the company's larger INR 534.64 crore capital raise initiated in October 2025 via preferential allotment. The conversion price was fixed at Rs. 185 per share, which includes a premium of Rs. 175. As a result, the company's total paid-up equity share capital has increased from 15.47 crore to 15.51 crore shares.
முக்கிய அம்சங்கள்
Allotment of 3,89,183 equity shares pursuant to conversion of Compulsorily Convertible Debentures (CCDs)Conversion price of Rs. 185 per share including a premium of Rs. 175Total paid-up equity capital increased to 15,50,95,936 shares from 15,47,06,753 sharesPart of a larger INR 534.64 crore capital raise through preferential allotmentNew equity shares will rank pari-passu with existing shares in all respects
👀 கவனிக்க வேண்டியவை
Investors should account for the marginal equity dilution resulting from this conversion. The focus should remain on how the company utilizes the total capital raised to expand its AUM and improve net interest margins.
UGRO Capital to Merge Subsidiary Profectus Capital; Increases CP Borrowing Limit to ₹800 Cr
UGRO Capital's board has approved the merger of its wholly-owned subsidiary, Profectus Capital Private Limited (PCPL), into the parent company to streamline operations and enhance its MSME lending portfolio. PCPL brings a significant net worth of ₹1,127.85 crore and total assets of ₹3,323.65 crore as of September 2025. Since PCPL is a 100% subsidiary, no new shares will be issued, ensuring zero equity dilution for existing shareholders. Additionally, the company has increased its Commercial Paper borrowing limit from ₹500 crore to ₹800 crore to bolster liquidity.
முக்கிய அம்சங்கள்
Merger of wholly-owned subsidiary Profectus Capital (PCPL) with UGRO Capital approved by the Board.PCPL reported H1 FY26 revenue of ₹216.38 crore and a net worth of ₹1,127.85 crore.UGRO Capital's standalone assets stood at ₹10,778.76 crore as of September 30, 2025.Zero equity dilution for shareholders as all PCPL shares held by UGRO will be cancelled.Commercial Paper borrowing limit increased by 60% from ₹500 crore to ₹800 crore.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive consolidation that simplifies the corporate structure and improves capital efficiency without diluting equity. Monitor the progress of NCLT and RBI approvals for the merger timeline.
UGRO Capital Re-opens Series 2 Non-Convertible Debentures (NCD) Issuance of INR 100 Crores
UGRO Capital has decided to re-open its Series 2 Non-Convertible Debentures (NCD) issuance, aggregating to INR 100 Crores. This decision follows a very recent withdrawal of the same issuance announced on December 22, 2025. The quick reversal suggests a stabilized plan for debt-based capital infusion. The funds are expected to support the company's lending operations and growth in the MSME sector.
முக்கிய அம்சங்கள்
Re-opening of Series 2 Non-Convertible Debentures (NCD) issuance for INR 100 Crores.The decision follows a withdrawal notice previously issued on December 22, 2025.The issuance is being conducted under Regulation 30 and 51 of SEBI LODR Regulations.The capital raise is aimed at strengthening the balance sheet for further credit disbursement.
👀 கவனிக்க வேண்டியவை
Investors should monitor the final coupon rates and tenure of these NCDs to assess the company's cost of funds. The successful closure of this INR 100 Crore raise will be a positive indicator of liquidity management.
UGRO Capital Withdraws Proposed Series 2 Non-Convertible Debenture (NCD) Issuance
UGRO Capital has announced the withdrawal of its proposed issuance of Non-Convertible Debentures (NCDs) under Series 2. This decision follows a previous approval by the Investment and Borrowing Committee on December 17, 2025, for a private placement of listed, rated, senior debt. The company cited 'internal considerations' as the reason for cancelling this specific series of the fundraise. Investors should note that this affects only the Series 2 tranche of the previously planned debt issuance.
முக்கிய அம்சங்கள்
Withdrawal of Series 2 NCD issuance previously approved on December 17, 2025The proposed instruments were listed, rated, senior, secured/unsecured NCDsDecision to withdraw was based on unspecified internal considerationsThe issuance was originally planned on a private placement basis
👀 கவனிக்க வேண்டியவை
Investors should monitor if the company announces alternative fundraising plans or if this withdrawal indicates a change in their immediate capital requirements. Observe the company's liquidity position in upcoming quarterly reports to ensure lending growth remains on track.
Ugro Capital Credit Rating Affirmed at 'A+'; Outlook Revised to Positive by India Ratings
India Ratings has affirmed Ugro Capital's long-term rating at 'IND A+' and revised the outlook to 'Positive' from 'Rating Watch', while CRISIL reaffirmed 'CRISIL A/Stable'. This resolution follows the successful acquisition of Profectus Capital (PCPL), which is expected to increase the consolidated Assets Under Management (AUM) to approximately ‑150 billion. The company recently strengthened its balance sheet with a ‑9.1 billion capital raise via CCDs and rights issues, maintaining a healthy capital adequacy ratio of 25.4%. The rating actions reflect improved product diversification and a strategic shift towards a higher proportion of secured lending.
முக்கிய அம்சங்கள்
India Ratings upgraded the outlook to 'Positive' from 'Rating Watch' for Bank Loans and NCDs.Consolidated AUM is projected to reach ‑150 billion following the PCPL acquisition, up from ‑122 billion in 1HFY26.Post-acquisition, the share of secured assets in the portfolio is expected to rise to nearly 85% from 78%.Capital adequacy remains robust at 25.4% with a leverage ratio of 3.3x as of Q2 FY26.The company has diversified its funding base to 59 lenders, including major public and private sector banks.
👀 கவனிக்க வேண்டியவை
The outlook upgrade to 'Positive' is a significant endorsement of the company's post-merger stability and could lead to lower borrowing costs. Investors should monitor the successful integration of PCPL and the impact of operational synergies on profitability margins.
Ugro Capital Allots 5.34 Lakh Shares on CCD Conversion; 2.04 Cr Warrants Lapse
Ugro Capital has approved the allotment of 5,34,088 equity shares following the mandatory conversion of Compulsorily Convertible Debentures (CCDs) at a price of Rs. 264 per share. This move increases the company's total paid-up equity capital to 15,47,06,753 shares. Significantly, 2,04,88,631 warrants issued in June 2024 have lapsed as they were not exercised within the 18-month tenure. The company also corrected a previous filing, noting that 1,74,54,450 warrants from an earlier tranche had also lapsed.
முக்கிய அம்சங்கள்
Allotment of 5,34,088 equity shares at a conversion price of Rs. 264 (including Rs. 254 premium)Paid-up equity capital increased from Rs. 154.17 crore to Rs. 154.71 croreLapse of 2,04,88,631 warrants issued on June 18, 2024, due to non-exercise by holdersCorrection of previously reported lapsed warrants from June 6, 2024, to 1,74,54,450 unitsThe conversion was mandatory following the expiry of the 18-month tenure of the CCDs
👀 கவனிக்க வேண்டியவை
Investors should account for the minor equity dilution and the fact that a large portion of the potential warrant-led capital infusion has lapsed. Monitor the company's capital adequacy and future fund-raising plans to support growth.
UGRO Capital Approves Fundraise of up to ₹700 Crores via NCD Issuance
UGRO Capital's Investment and Borrowing Committee has approved the issuance of Non-Convertible Debentures (NCDs) on a private placement basis. The issue features a base size of ₹200 Crores with a green shoe option to retain oversubscription of up to ₹500 Crores, totaling a potential ₹700 Crores. The NCDs are divided into four series with tenures ranging from 13 to 24 months. This capital infusion is intended to support the company's lending operations and liquidity management.
முக்கிய அம்சங்கள்
Base issue size of ₹200 Crores with a Green Shoe option of ₹500 Crores.Issuance consists of four series, with Series 1-3 being secured and Series 4 being unsecured.Tenures range from 13 months (Series 3) to 24 months (Series 1, 2, and 4).Series 2 carries a tentative coupon rate of 9.75% per annum with quarterly interest payments.Security cover for secured series is set at 1.1x or through specific asset/investment pledges.
👀 கவனிக்க வேண்டியவை
Investors should monitor the successful completion of this fundraise as it provides necessary capital for UGRO's MSME lending growth. The 9.75% tentative coupon for Series 2 indicates the current cost of borrowing for the firm, which is a key metric for NBFC profitability.
UGRO Capital Allots Secured NCDs Worth INR 150 Crore at 9.99% Interest
UGRO Capital has successfully allotted 1,50,000 secured, non-convertible debentures (NCDs) through a private placement, raising a total of INR 150 crore. These instruments carry a coupon rate of 9.99% per annum, with interest payable on a monthly basis. The NCDs have a tenure of 42 months and are backed by a security cover of 1.10x over the company's loan receivables. This capital infusion is expected to support the company's ongoing lending operations and growth strategy.
முக்கிய அம்சங்கள்
Allotment of 1,50,000 NCDs with a face value of INR 10,000 each, totaling INR 150 croreFixed coupon rate of 9.99% per annum with a monthly payment scheduleInstrument tenure is 42 months with a maturity date set for June 16, 2029Secured by a minimum 1.10x cover on present and future loan receivablesThe NCDs will be listed on the BSE Limited for secondary market trading
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's deployment of these funds into high-yield SME lending to ensure net interest margins remain stable. The successful fundraise at a sub-10% rate indicates healthy credit confidence in the NBFC.
Ugro Capital Board to Meet on December 17 to Approve Fundraise via NCDs
Ugro Capital has announced a meeting of its Investment and Borrowing Committee scheduled for December 17, 2025. The committee will consider and approve the raising of funds through the issuance of Non-Convertible Debentures (NCDs) on a private placement basis. This move is a standard capital-raising activity for the NBFC to support its lending operations and growth in the MSME sector. While the specific amount has not been disclosed yet, the outcome of the meeting will determine the scale of the capital infusion.
முக்கிய அம்சங்கள்
Investment and Borrowing Committee meeting scheduled for December 17, 2025.Proposal to raise funds via issuance of Non-Convertible Debentures (NCDs).Fundraising to be conducted through a private placement basis.Complies with SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations.
👀 கவனிக்க வேண்டியவை
Investors should monitor the post-meeting announcement on December 17 for the specific quantum of funds and the interest rates offered. Successful capital raising at competitive rates is essential for the company's credit growth and margin stability.
UGROCAP Allots 15,89,170 Equity Shares on CCD Conversion
Ugro Capital Limited has allotted 15,89,170 equity shares following the conversion of Compulsorily Convertible Debentures (CCDs). The conversion price was ₹185 per share, including a premium of ₹175. This allotment increases the company's issued, subscribed, and paid-up equity share capital from ₹1,52,58,34,950 to ₹1,54,17,26,650. The new shares rank equally with existing shares.
முக்கிய அம்சங்கள்
Allotted 15,89,170 Equity SharesConversion price of ₹185 per sharePremium of ₹175 per equity shareEquity share capital increased to ₹1,54,17,26,650 from ₹1,52,58,34,950CCDs converted into equity shares
👀 கவனிக்க வேண்டியவை
Investors should note the increase in equity share capital. Monitor the company's performance and financial statements for any impact from this conversion.
Ugro Capital Allots Unlisted Commercial Papers of ₹50 Crores
Ugro Capital Limited has announced the allotment of unlisted Commercial Papers (CPs) worth ₹50 Crores. The allotment was approved by the Investment and Borrowing Committee of the Board of Directors on December 10, 2025. These CPs have a face value of ₹5,00,000 per security and were issued at a price of ₹4,95,964.50 per security. The redemption date is set for January 12, 2026, with a redemption value of ₹50,00,00,000.
முக்கிய அம்சங்கள்
Allotted unlisted Commercial Papers worth ₹50 Crores.Face value per security is ₹5,00,000.Issue price per security is ₹4,95,964.50.Redemption value is ₹50,00,00,000.Tenure of the security is 33 Days.
👀 கவனிக்க வேண்டியவை
Investors should note the company's short-term funding strategy and monitor its impact on the company's financials. Review the company's future announcements regarding debt and financial performance.
UGRO Capital Completes 100% Acquisition of Profectus Capital; AUM Reaches ₹15,471 Cr
UGRO Capital has finalized the 100% acquisition of Profectus Capital, expanding its consolidated AUM by 29% to ₹15,471 crore. The deal is highly accretive, providing an immediate ₹150 crore in annualized profit and an additional ₹115 crore in expected operating synergies. The acquisition shifts the company's asset mix to 75% secured, which is projected to improve Return on Assets (ROA) by 60-70 bps. Furthermore, the transaction opens a new ₹2,000 crore medium-term market opportunity in school financing.
முக்கிய அம்சங்கள்
Consolidated AUM grew by 29% to ₹15,471 crore with the addition of Profectus's ₹3,468 crore bookImmediate annualized profit accretion of ₹150 crore delivered on Day 1 with zero origination costExpected operating synergies of ₹115 crore to drive a 60-70 bps improvement in ROAAsset mix significantly strengthened to 75% secured, enhancing earnings stability and credit-cost profilesEntry into school financing creates a new ₹2,000 crore medium-term growth vertical
👀 கவனிக்க வேண்டியவை
Investors should view this acquisition as a significant positive catalyst for earnings growth and ROE improvement. Monitor the upcoming formal merger process and the realization of the projected ₹115 crore in operating synergies.
UGROCAP acquires Profectus Capital as wholly owned subsidiary
UGRO Capital Limited has completed the acquisition of 100% shareholding in Profectus Capital Private Limited, making it a wholly owned subsidiary effective December 8, 2025. This acquisition was initially announced on June 17, 2025, and received RBI approval as disclosed on September 18, 2025. The acquisition was executed under the Share Purchase Agreement (SPA) dated June 17, 2025. This move is expected to strengthen UGRO Capital's position in the market.
முக்கிய அம்சங்கள்
Acquired 100% shareholding in Profectus Capital Private LimitedProfectus is now a wholly owned subsidiary of UGRO Capital effective December 8, 2025Acquisition follows Share Purchase Agreement (SPA) dated June 17, 2025RBI approval received as per disclosure on September 18, 2025
👀 கவனிக்க வேண்டியவை
Investors should monitor UGRO Capital's performance and integration of Profectus Capital to assess the long-term benefits of this acquisition. Keep an eye on future announcements regarding synergies and financial impact.
UGROCAP: Allotment of 7,342,732 Equity Shares on CCD Conversion
UGRO Capital has allotted 7,342,732 equity shares due to the conversion of Compulsorily Convertible Debentures (CCDs). The conversion was triggered as the 18-month tenure of CCDs allotted on June 6, 2024, expired. The face value of each equity share is ₹10, and the conversion price was ₹264 (including a premium of ₹254). Consequently, the issued, subscribed, and paid-up equity share capital increased from 14,52,40,763 shares (₹1,45,24,07,630) to 15,25,83,495 shares (₹1,52,58,34,950). Additionally, 1,76,34,374 warrants that were not converted have lapsed.
முக்கிய அம்சங்கள்
Allotted 7,342,732 Equity Shares on CCD conversionEquity share face value is ₹10 eachConversion price of ₹264 per share (including ₹254 premium)Issued capital increased to 15,25,83,495 equity shares, amounting to ₹1,52,58,34,9501,76,34,374 warrants lapsed due to non-conversion
👀 கவனிக்க வேண்டியவை
Investors should note the increase in equity share capital and potential dilution. Monitor the company's performance and future announcements regarding warrant conversions.
UGRO Capital Limited has announced the allotment of Commercial Papers (CPs) worth ₹30,00,00,000. The allotment date is December 5th, 2025, and the redemption date is June 3rd, 2026, giving the security a tenure of 180 days. The face value per security is ₹5,00,000, while the issue price is ₹4,78,525.50 per security. The ISIN for these CPs is INE583D14766.
முக்கிய அம்சங்கள்
Allotment of Commercial Papers worth ₹30,00,00,000Face Value per Security: ₹5,00,000Issue Price per Security: ₹4,78,525.50Tenure of the security: 180 daysRedemption Date: June 3rd, 2026
👀 கவனிக்க வேண்டியவை
Investors should monitor UGRO Capital's financial performance and its ability to meet its obligations related to these commercial papers. Review the company's credit ratings for further insights.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
